The next focusIR Investor Webinar takes place tomorrow with guest speakers from WS Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRM2.L Regulatory News (RM2)

  • There is currently no data for RM2

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

20 Feb 2017 07:00

RNS Number : 2463X
RM2 International SA
20 February 2017
 

20 February 2017

 

 

RM2 International S.A.

("RM2" or the "Company")

 

Director / PDMR Shareholding

 

RM2 (LSE-AIM: RM2), the sustainable composite pallet innovator ("the Company"), today announces that, similar to 2016, its Non-Executive Directors are to receive ordinary shares of US$0.01 each in the Company ("Ordinary Shares") in lieu of cash payment of directors' fees for the 2017 calendar (the "2017 Director Fee Arrangement").

Pursuant to the 2017 Director Fee Arrangement, the Company is to issue in aggregate, 1,315,000 new Ordinary Shares (the "Fee Shares") to the Non-Executive Directors in two equal semi-annual instalments. As detailed below, 657,500 Fee Shares were issued on February 17, 2017 with respect to the first semester of 2017 ("H1 Fee Shares"). Shares with respect to the second semester of 2017 will be issued to the Non-Executive Directors following the Company's Annual General Meeting.

The Directors have agreed that the Fee Shares shall not be sold or voted until the relevant semi-annual period has completed and the volume weighted average market price of the Ordinary Shares has been greater than or equal to 100 pence for a consecutive 30-day period.

The Fee Shares are issued pursuant to the Company's Employee Share Option Plan.

The number of Fee Shares to be issued has been calculated on the basis of the closing mid-market price per Ordinary Share of 27.5 pence on 16 February 2017, being the latest practicable date prior to publication of this announcement, and at an exchange rate of approximately USD/GBP: 0.80.

Separately, 100,000 new Ordinary Shares (the "FdM Shares") have been issued to Frederic de Mevius for directors' fees due following his appointment to the Board of RM2 on July 18, 2016.

Taking into account the issue of the H1 Fee Shares and the FdM Shares, the current shareholdings of the Non-Executive Directors of the Company are as follows:

 

No. of H1 Fee Shares / FdM Shares issued

Total number of Ordinary Shares held2

% of enlarged voting share capital

R. Ian Molson

 117,500

 11,392,500

2.57%

Jan Dekker

 90,000

 2,790,000

0.63%

Charles Duro

 90,000

 627,500

0.14%

Frederic de Mevius

 190,0001

 190,000

0.04%

Lord Rose

 90,000

 1,440,000

0.33%

Amaury de Seze

 90,000

 1,740,000

0.39%

Paul Walsh

 90,000

 2,029,091

0.46%

1 Includes the FdM Shares

2 Includes restricted shares held

 

Related Party Transactions

The 2017 Director Fee Arrangement and the issue of the FdM Shares are deemed to be related party transactions pursuant to Rule 13 of the AIM Rules for Companies. Accordingly, the independent directors for the purposes of the 2017 Director Fee Arrangement and the issue of the FdM Shares, being John Walsh and Jean-Francois Blouvac, having consulted with the Company's Nominated Adviser, Strand Hanson Limited, consider that the terms of the 2017 Director Fee Arrangement and the issue of the FdM Shares are fair and reasonable insofar as the Company's shareholders are concerned.

 

Admission to trading

Application has been made to the London Stock Exchange for the admission to trading on AIM of the H1 Fee Shares and FdM Shares, which will rank pari passu with the Ordinary Shares, and which is expected to become effective on 24 February 2017 ("Admission").

Following Admission, the Company's issued share capital will be composed of 401,062,656 Ordinary Shares and 42,328,042 Convertible Preferred Shares of US$0.01 each in the capital of the Company, of which 379,334 Ordinary Shares are held by the Company as non-voting treasury stock. The total number of voting rights in the Company is 443,011,364. This figure of 443,011,364 may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or change their interest in, the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

The Ordinary Shares are listed on the AIM Market of the London Stock Exchange.

 

For further information, please contact:

 

RM2 International S.A.

+44 (0)20 8820 1412

John Walsh, Chief Executive Officer

Jean-Francois Blouvac, Chief Financial Officer

Strand Hanson Limited (Nominated & Financial Adviser)

+44 (0) 20 7409 3494

James Spinney

Ritchie Balmer

James Bellman

 

 

Zeus Capital Limited (Joint Broker)

+44 (0) 20 3829 5000

Giles Balleny

Hugh Kingsmill Moore

 

RBC Capital Markets (Joint Broker)

+44 (0) 20 7653 4000

Tristan LovegroveEma Jakasovic

Citigate Dewe Rogerson

+44 (0)20 7638 9571

Simon Rigby

Rob Newman

Ellen Wilton

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014 ("MAR").

 

Notes to Editors

 

RM2 International S.A. specialises in pallet development, manufacture, supply and management to establish a leading presence in global pallet supply and improve the supply chain of manufacturing and distribution businesses through the effective and efficient use and management of composite pallets. It is quoted on the AIM market of the London Stock Exchange under the symbol RM2.L.

 

For further information, please visit www.rm2.com 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHDGGDDCXBBGRC
Date   Source Headline
17th Jan 202011:04 amRNSHolding(s) in Company
16th Jan 20205:30 pmRNSRM2 International
16th Jan 20207:00 amRNSResult of GM, Cancellation & Asset Match appt
6th Jan 202011:15 amRNSHolding(s) in Company
31st Dec 201911:00 amRNSIssuance of Shares, Director Shareholdings and TVR
18th Dec 20197:00 amRNSCancellation from trading on AIM and Notice of EGM
12th Dec 201911:59 amRNSHolding(s) in Company
12th Dec 201911:56 amRNSHolding(s) in Company
29th Nov 20197:00 amRNSIssuance of Shares, Director Shareholdings and TVR
12th Nov 20195:37 pmRNSHolding(s) in Company
7th Nov 201910:33 amRNSHolding(s) in Company
5th Nov 20192:15 pmRNSHolding(s) in Company
31st Oct 20192:01 pmRNSIssuance of Shares, Director Shareholdings and TVR
25th Oct 20193:45 pmRNSHolding(s) in Company
25th Oct 20193:45 pmRNSHolding(s) in Company
23rd Oct 201911:30 amRNSHolding(s) in Company
23rd Oct 201911:30 amRNSHolding(s) in Company
2nd Oct 20197:00 amRNSIssuance of Shares, Director Shareholdings and TVR
25th Sep 20193:34 pmRNSAccounts publication timetable and Board changes
18th Sep 20191:12 pmRNSHolding(s) in Company
10th Sep 20192:55 pmRNSHolding(s) in Company
2nd Sep 20191:54 pmRNSIssuance of Shares, Director Shareholdings and TVR
28th Aug 201912:34 pmRNSHolding(s) in Company
27th Aug 20197:00 amRNSDirector Shareholdings
5th Aug 20195:00 pmRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
5th Aug 20197:00 amRNSHolding(s) in Company
31st Jul 20192:48 pmRNSResult of EGM, Placing proceeding and TVR
23rd Jul 20197:00 amRNSConditional Placing, GM Notice and Contract Update
17th Jul 201911:45 amRNSHolding(s) in Company
15th Jul 20195:30 pmRNSHolding(s) in Company
1st Jul 20197:30 amRNSSuspension - RM2 International S.A.
1st Jul 20197:30 amRNSSuspension of Trading on AIM and TVR Update
26th Jun 20197:00 amRNSAccounts Publication Timetable and Trading Update
5th Apr 201910:15 amRNSIssue of Shares to Directors
28th Mar 20193:51 pmRNSTrading Update and TVR Update
15th Jan 201912:00 pmRNSTotal Voting Rights
28th Dec 20182:00 pmRNSIssue of Shares to Directors and Employees
24th Dec 20187:00 amRNSVAT News
12th Dec 20184:29 pmRNSTotal Voting Rights
11th Dec 20184:22 pmRNSResult of EGM
23rd Nov 20182:45 pmRNSShare Capital Restructuring,Placing, Notice of EGM
8th Nov 201812:07 pmRNSTransfer Pricing Audit
3rd Oct 20182:35 pmRNSResult of EGM
18th Sep 20187:00 amRNSSignificant Contract
14th Sep 20187:00 amRNSBoard Appointments
14th Sep 20187:00 amRNSInterim Results
7th Sep 20187:00 amRNSTrading Update and New Board Appointments
15th Jun 20181:09 pmRNSResult of Open Offer
5th Jun 20184:07 pmRNSUpdate on Open Offer

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.